February 25, 2026 — RNews

#cmv — Wednesday, February 25, 2026 (1 items)

hot top new

← prev day next day →

0

Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients. (academic.oup.com)

Limaye AP … Haber B Clinical Infectious Diseases 2026-02-25

#infection #immunity #prophylaxis #transplantation #cmv